MedTrace Logo

Cardiovascular Toxicity Induced by Antitumoral Drugs: Risk Assessment and Early Diagnosis. CARDIOTOX Registry

NCT02039622 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3400

Last updated 2014-01-17

No results posted yet for this study

Summary

The study is multicenter, post-authorization, observational and ambispective

Conditions

  • Cardiovascular Toxicity Induced by Antitumoral Drugs

Sponsors & Collaborators

  • Instituto de Investigación Hospital Universitario La Paz

    lead OTHER

Principal Investigators

  • Jose Luis Lopez-Sendon · La Paz University Hospital- Chief of Cardiology Department

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2016-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02039622 on ClinicalTrials.gov